Genmab and Bionomics to co-develop human antibodies for angiogenesis targets
Genmab and Bionomics, announced today that they will collaborate to create and develop fully human antibodies to angiogenesis targets identified by Bionomics. Under the terms of the collaboration agreement, the two companies will share equally in the resea
12-Mar-2002 -
Copenhagen, Denmark and Adelaide, Australia; March 11, 2002
Genmab A/S and Bionomics Limited , announced today that they will collaborate to create and develop fully human antibodies to angiogenesis targets identified by Bionomics.
Under the terms of the collaboration agreement, the two ...
angiogenesis
antibodies
assays
+8